Website profile

scr.zacks.com

Zacks Small Cap Research coverage specifically looks to focus on small and micro-cap companies that are under followed or under valued by Wall Street.

  • 38articles · 30d
  • 3+ day agolatest article
  • Aug 17, 2026earliest in window
  • 0%with images
  • 298avg words
articles per day
Categories
  • Economy, Business & Finance 33
  • Finance & Business 25
  • News 21
  • Health & Wellness 10
  • Medical 8
  • Business & Industrial 6
  • Industrial 5
  • Health 4

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

scr.zacks.com
scr.zacks.com > news > news-details > 2026 > HCTI-Spins-off-Teyame-to-Benefit-Shareholders > default.aspx

HCTI Spins off Teyame to Benefit Shareholders

3+ day, 13+ hour ago   (134+ words) Those numbers help explain why separating Teyame into its own publicly traded company could be strategically significant. Creating an independently traded Teyame could change that dynamic. Once Teyame has its own listing, investors should have a much clearer market reference…...

scr.zacks.com
scr.zacks.com > news > news-details > 2026 > HURA-Milestone-Progression-Over-Next-12-Months > default.aspx

HURA: Milestone Progression Over Next 12 Months

2+ week, 4+ day ago   (71+ words) READ THE FULL HURA RESEARCH REPORT TuHURA generated no revenues in 2Q:26 and expended $8.8 million on operational activities related to advancing IFx-2.0, TBS-2025, and other programs, producing a net loss of $9.2 million or $0.14 per share. For the quarter ending June 30th, 2026, and…...

scr.zacks.com
scr.zacks.com > news > news-details > 2026 > GRRR-The-Good-Raised-Guidance-The-Bad-Short-term-Margin-Pressure-and-The-Ugly-Retail-Traders-Are-Not-Investors-article > default.aspx

GRRR: The Good (Raised Guidance), The Bad (Short-term Margin Pressure), and The Ugly (Retail Traders Are Not Investors)

2+ week, 5+ day ago   (200+ words) By Brian Lantier, CFA READ THE FULL GRRR RESEARCH REPORT After the market closed on August 24, Gorilla Technology Group (NASDAQ: GRRR) released its second-quarter results for 2026, which continue to show that Gorilla is executing on its existing contracts successfully. Below…...

scr.zacks.com
scr.zacks.com > news > news-details > 2026 > IZOZF-Making-Strides > default.aspx

Zacks Small Cap Research - IZOZF Making Strides

2+ week, 5+ day ago   (1453+ words) By Brad Sorensen, CFA OTCQB: IZOZF | CSE: IZO READ THE FULL IZOZF RESEARCH REPORT With the investment world increasingly interested in smaller companies in search of value and growth, we want to highlight one of our favorite ideas for investors....

scr.zacks.com
scr.zacks.com > news > news-details > 2026 > BSIN-Big-Sky-Industrials-Strong-Revenue-and-EBITDA-Growth-Expected-in-2027-Supports-Price-Target-of-3-50 > default.aspx

BSIN: Big Sky Industrial’s Strong Revenue and EBITDA Growth Expected in 2027 Supports Price Target of $3.50

3+ week, 5+ day ago   (286+ words) By Tom Kerr, CFA READ THE FULL BSIN RESEARCH REPORT 2nd Quarter 2026 Financial & Operating Results Big Sky Industrial’s (NASDAQ: BSIN) quarterly financial results were mostly related to legacy oil & gas operations, with about 86% coming from the Montana region and the remainder…...

scr.zacks.com
scr.zacks.com > news > news-details > 2026 > GXAI-Gaxos-AI-Sells-Off-Its-Gaming-Business-for-a-One-Time-Gain > default.aspx

GXAI: Gaxos.AI Sells Off Its Gaming Business for a One-Time Gain

3+ week, 6+ day ago   (1098+ words) By Lisa Thompson NASDAQ: GXAI READ THE FULL GXAI RESEARCH REPORT Gaxos.AI (NASDAQ: GXAI) again beat on its top line as advertising spend resulted in higher revenues than we expected for both businesses. While revenues beat our estimate, the…...

scr.zacks.com
scr.zacks.com > news > news-details > 2026 > CTSO-CytoSorbents-Future-Value-Drivers-Support-Price-Target-of-4-00 > default.aspx

CTSO: CytoSorbents Future Value Drivers Support Price Target of $4.00

3+ week, 6+ day ago   (127+ words) By Tom Kerr, CFA READ THE FULL CTSO RESEARCH REPORT 2nd Quarter 2026 Financial Results Based on 2nd quarter 2026 results and management commentary, we adjust our full year 2026 revenue estimate to $38.1 million and adjust our 2026 non-GAAP loss per share to ($0.22). We believe 2027 revenues…...